PUBLIC MEETING
FDA Science Board Friday, April 13, 2001 9:00 a.m. - 4:30 p.m. Room 1066, 5630 Fishers Lane, Rockville, MD.
The Science Board provides advice to the Commissioner, Deputy Commissioner, Senior Advisor for Science and other agency officials on specific technical emerging issues within the scientific community in government, industry and academia. Additionally, they provide advice on keeping pace with evolutions in the fields of regulatory science; formulating a research agenda; and enhancing research facilities. AGENDA: 9:00 a.m. Call to Order Science Board Chair Introductory Remarks Bernard A. Schwetz, D.V.M., Ph.D., Acting Principal Deputy Commissioner, FDA 9:15 a.m. Update on Action Items from November 2000 meeting Elizabeth D. Jacobson, Ph.D., Acting Senior Advisor for Science Update on Science Review David W. Feigal, Jr., M.D., M.P.H., Director, Center for Devices & Radiological Health Dennis Baker, Associate Commissioner for Regulatory Affairs 10:30 a.m. Discussion FDA Science Board Break Emerging Science Issue: Tissue and Tissue Engineered Products Kathryn Zoon, Ph.D., Director, Center for Biologics Evaluation & Research David W. Feigal, Jr., M.D., M.P.H., Director, Center for Devices & Radiological Health Discussion FDA Science Board Lunch Open Public Comment OWH Research Program Update Susan Wood, Ph.D., Director, Office of Women’s Health, FDA Discussion FDA Science Board Preparing to Meet Scientific Workforce Challenges How Scientists in a Non-Academic Institution Keep Up With Cutting Edge Science
9:30 a.m.
11:00 a.m. 11:15 a.m.
11:45 a.m.
12:00 1:00 p.m. 1:30 p.m.
2:00 p.m.
2:30 p.m.
Edward Scolnick, M.D., FDA Science Board President, Merck Research Laboratories FDA University Concept Jim Heslin, Training Officer, Food & Drug Administration 4:00 p.m. 4:30 p.m. Science Board Discussion/Closing Remarks/Future Direction Adjourn